Tokyo, Sept. 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062387) titled 'A multi-institutional retrospective observational study on the clinical safety and efficacy of Central Dialysis fluid Delivery System (CDDS)' on Sept. 8.
Study Type:
Observational
Primary Sponsor:
Institute - Toray Medical Company Limited
Condition:
Condition - chronic renal failure
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - We evaluate the clinical safety and efficacy of Central Dialysis fluid Delivery System (CDDS).
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Chronic hemodialysis patients who receive maintenance hemodialysis at a frequency of 3 times / week at the institutions during the clinical data collection period
2) Patients who are 18 years or older at the time of registration (no age-upper limit)
3) Patients who receive dialysis in modes other than ECUM (UF) during the clinical data collection period
4) Patients who undergo a routine blood test at least once a month as part of regular medical treatment during the clinical data collection period
Key exclusion criteria - 1) Patients who use continuous ambulatory peritoneal dialysis (CAPD) together during the clinical data collection period
2) Patients who are judged inappropriate for inclusion in this study by the investigators
Target Size - 120
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 06 Day
Anticipated trial start date - 2026 Year 08 Month 07 Day
Last follow-up date - 2026 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071398
Disclaimer: Curated by HT Syndication.
